Growth Metrics

Solid Biosciences (SLDB) Change in Cash (2017 - 2024)

Historic Change in Cash for Solid Biosciences (SLDB) over the last 8 years, with Q4 2024 value amounting to $15.9 million.

  • Solid Biosciences' Change in Cash fell 3649.61% to $15.9 million in Q4 2024 from the same period last year, while for Dec 2024 it was $6.3 million, marking a year-over-year increase of 10779.04%. This contributed to the annual value of $6.3 million for FY2024, which is 10779.04% up from last year.
  • According to the latest figures from Q4 2024, Solid Biosciences' Change in Cash is $15.9 million, which was down 3649.61% from -$31.4 million recorded in Q3 2024.
  • In the past 5 years, Solid Biosciences' Change in Cash ranged from a high of $129.9 million in Q4 2020 and a low of -$90.9 million during Q3 2021
  • Its 5-year average for Change in Cash is $290850.0, with a median of -$9.1 million in 2020.
  • In the last 5 years, Solid Biosciences' Change in Cash surged by 103532.24% in 2022 and then plummeted by 67036.77% in 2023.
  • Quarter analysis of 5 years shows Solid Biosciences' Change in Cash stood at $129.9 million in 2020, then plummeted by 92.79% to $9.4 million in 2021, then soared by 1035.32% to $106.4 million in 2022, then crashed by 76.51% to $25.0 million in 2023, then crashed by 36.5% to $15.9 million in 2024.
  • Its last three reported values are $15.9 million in Q4 2024, -$31.4 million for Q3 2024, and -$21.6 million during Q2 2024.